Covid-19
The New England Journal of Medicine
TAKE-HOME MESSAGE
This retrospective study evaluated
the effectiveness of the Pfizer (BNT162b2) COVID-19 vaccine in preventing
reinfection in patients who had recovered from COVID-19.
A total of 149,039 patients who had
recovered from COVID-19 were included, and, of these, 56% were subsequently...
The New England Journal of Medicine
Real-world studies have shown the
short-term effectiveness of vaccines with respect to symptomatic and
asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections,
the severity of Covid-19, and secondary transmission. The duration of this
protection over longer periods remains...
INTRODUCTION
Coronavirus
disease 2019 (COVID-19) has increased the frequency of hand washing. There is
scarce evidence regarding the impact of different hand hygiene procedures on
skin barrier function in clinical practice.
For the
required proper hand hygiene procedures, currently there are several hand
hygiene products available, s...
What is already known about this
topic?
Face masks or respirators
(N95/KN95s) effectively filter virus-sized particles in laboratory settings.
The real-world effectiveness of face coverings to prevent acquisition of
SARS-CoV-2 infection has not been widely studied.
What is added by this report?
Consistent use of a face mask or
res...
The use of empiric antibiotic therapy
appears to prevent neither deterioration nor death among patients with COVID-19
pneumonia, as shown in this study.
Take Home Message
In a group of patients with
COVID-19 pneumonia, antibiotics were commonly started in those who were
severely ill. Patients who did vs did not receive antibiotics mor...
The New England Journal of Medicine
Infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and illness
with the associated coronavirus disease 2019 (Covid-19) continue to threaten
global health.
Persons
with particular characteristics such as older age, current smoking, or
underlying clinical conditions such as...
Effectiveness
of Maternal Vaccination with mRNA COVID-19 Vaccine during Pregnancy against
COVID-19–Associated Hospitalization in Infants Aged
JAMA Internal Medicine
Ivermectin
treatment during early illness does not prevent progression to severe disease
for high-risk patients with mild-to-moderate COVID-19, according to a study
published online Feb. 18 in JAMA
Internal Medicine.
An in
vitro study demonstrated inhibitory effects of ivermectin against SARS-CoV-2.
Although s...
Clinical Infectious Diseases: By
Infectious Diseases Society of America
TAKE-HOME MESSAGE
This study addressed the predictors
of SARS-CoV-2 infection among participants who reported social contact with an
individual known or suspected of having SARS-CoV-2 infection. Among
unvaccinated and partially vaccinated participants, factors suc...
JAMA Internal Medicine:
Key Points
Question What
is the risk of perinatal complications associated with SARS-CoV-2 infection
during pregnancy and what factors are associated with hospitalizations?
Findings In
this cohort study of 43 886 pregnant individuals, SARS-CoV-2 infection during
pregnancy was associated with an increased ris...
Journal of the American College of Nutrition:
It is widely recognized that COVID-19 severity is a multifactorial
condition; several risk factors have been identified, including advanced
age, ethnicity, type 2 diabetes, hypertension, obesity, renal dysfunction, and
cardiovascular diseases.
Interestingly, each of these factors
is also...
BMJ: British Medical Journal
This
retrospective case series analysis compared the incidence of immune-mediated
neurologic events among over 8 million individuals vaccinated against COVID-19,
over 700,000 unvaccinated individuals diagnosed with COVID-19, and a historical
cohort of over 14 million individuals in the general population....
